Hematopoietic stem cell transplantation for the treatment of autoimmune diseases |
| |
Authors: | A Suwa |
| |
Institution: | (1) Department of Internal Medicine, Keio University School of Medicine, 35 Shinanomachi, Shinjuku-ku, Tokyo 160-8582, Japan Tel. +81-3-5363-3786; Fax +81-3-5039-5037 e-mail: suwa@med.keio.ac.jp, JP |
| |
Abstract: | Systemic autoimmune diseases that are resistant to conventional treatment cause considerable morbidity and mortality. Although
aggressive new approaches to treating autoimmune diseases have been developed over the past decade, there are still patients
with a severe, progressive, and life-threatening course. Based on animal studies and experience in the treatment of hematological
disorders with preexisting autoimmune disease, hematopoietic stem cell transplantation has been proposed for the treatment
of severe autoimmune diseases. Immunoablation and subsequent autologous peripheral blood stem cell transplantation using CD34+ hematopoietic cells with T cell depletion have been used for selected severe autoimmune diseases at many institutes in Australia,
Europe, and the United States. However, it is necessary to assess the efficacy and safety of this therapy compared with conventional
and other newly emerging therapies. |
| |
Keywords: | Autoimmune disease Bone marrow Hematopoietic stem cell transplantation Therapy |
本文献已被 SpringerLink 等数据库收录! |
|